improving Oncology exploration with Integrated KRAS Assay expert services and RAS Assays
within the speedily evolving area of oncology investigate, correct and productive mutation screening is essential for establishing specific therapies. The KRAS providers Platform performs a pivotal position During this landscape by featuring comprehensive remedies for KRAS mutation profiling and analysis. KRAS mutations, present in close to 95% of